Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes.

Korkmaz F. N., Gökçay Canpolat A., Güllü S.

Endocrinologia, diabetes y nutricion, vol.69, pp.354-361, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69
  • Publication Date: 2022
  • Doi Number: 10.1016/j.endinu.2021.07.002
  • Journal Name: Endocrinologia, diabetes y nutricion
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.354-361
  • Keywords: Lipohypertrophy, Uttrasonography, Diabetes mellitus, Insulin treatment, SKIN
  • Ankara University Affiliated: Yes

Abstract

Introduction: Insulin, which is used in the treatment of diabetes mellitus (DM), may lead to the development of lipohypertrophy (LH) which can negatively affect the management of diabetes mellitus. Two common methods to detect LH are palpation and superficial subcutaneous ultrasonography (SSU). We investigated the frequency of non-palpable LH using SSU, as well as examining risk factors.